chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Chills; Nausea; Vomiting; Heavy chest; Restlessness; Ache; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 01May2021 at 11:30 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history included PCOS (polycystic ovarian syndrome), vulvodynia and COVID-19. Concomitant medications included paracetamol (TYLENOL), ibuprofen (MOTRIN), loratadine (MANUFACTURER UNKNOWN) and diphenhydramine hydrochloride (BENADRYL); for unknown indications and from an unknown date. Past drug history included any protein pump inhibitor, latex, cinnamon, coconut and berberine (MANUFACTURER UNKNOWN). Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 01May2021, the patient experienced chills, nausea, vomiting, heavy chest, restlessness and ache. The clinical outcomes of the events chills, nausea, vomiting, heavy chest, restlessness and ache were not recovered at the time of reporting.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Heart rate increased, Pain, Paraesthesia
Clinical narrative: Headache; Piercing pain on injection side and a few other spots in thighs and legs; Rapid heart rate; Tingling in the back of both hands; Extreme tiredness; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 05Apr2021 at 18:15 (at the age of 46-year-old) as a single dose for COVID-19 immunisation.  Patient has no medical history. Past drug history include pork and its derivatives and bees Concomitant medications included ibuprofen (ADVIL) ascorbic acid, calcium carbonate, calcium pantothenate, calcium phosphate, chromium, cyanocobalamin, folic acid, magnesium carbonate, magnesium hydroxide, manganese gluconate, nicotinic acid, potassium bicarbonate, potassium carbonate, potassium phosphate dibasic, pyridoxine hydrochloride, quercetin, riboflavin sodium phosphate, sodium bicarbonate, sodium phosphate, thiamine hydrochloride, thioctic acid, zinc ascorbate (EMERGEN C), zinc lactate (ZINC) and birth control pills (unspecified) all taken for unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 18:30 the patient experienced headache, piercing pain on injection side and a few other spots in thighs and legs all within 15 minutes of vaccine. Patient also experienced extreme tiredness and what felt like rapid heart rate for 2-3 days following vaccine. The clinical outcome of the event headache, piercing pain on injection side and a few other spots in thighs and legs, extreme tiredness and tingling in the back of both hands was resolved on an unknown date in 2021; while that of rapid heartrate was resolved on an unknown date in Apr2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Myalgia, Nausea, Neck pain
Clinical narrative: Shoulder pain; Neck pain; Extreme tiredness; Extreme body ache; Muscle pain; Nausea; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 26Apr2021 at 18:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Concomitant medications included ibuprofen (ADVIL), ascorbic acid, calcium carbonate, calcium pantothenate, calcium phosphate, chromium, cyanocobalamin, folic acid, magnesium carbonate, magnesium hydroxide, manganese gluconate, nicotinic acid, potassium bicarbonate, potassium carbonate, potassium phosphate dibasic, pyridoxine hydrochloride, quercetin, riboflavin sodium phosphate, sodium bicarbonate, sodium phosphate, thiamine hydrochloride, thioctic acid, zinc ascorbate (EMERGEN C), zinc (MANUFACTURER UNKNOWN), all taken from unknown dates for unspecified indications and birth control pills (MANUFACTURER UNKNOWN). The patient previously took pork and its derivatives and bees. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05Apr2021 at 18:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Apr2021, within 15 minutes of vaccine, the patient experienced severe neck and shoulder pain on injection side and on the same day, the patient experienced extreme tiredness, extreme body ache, muscle pain and nausea. The clinical outcome of the events severe neck and shoulder pain on injection side, extreme tiredness, extreme body ache, muscle pain and nausea were resolved on an unknown date in Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Shoulder pain; Neck pain; Extreme tiredness; Extreme body ache; Muscle pain; Nausea; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 26Apr2021 at 18:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Concomitant medications included ibuprofen (ADVIL), ascorbic acid, calcium carbonate, calcium pantothenate, calcium phosphate, chromium, cyanocobalamin, folic acid, magnesium carbonate, magnesium hydroxide, manganese gluconate, nicotinic acid, potassium bicarbonate, potassium carbonate, potassium phosphate dibasic, pyridoxine hydrochloride, quercetin, riboflavin sodium phosphate, sodium bicarbonate, sodium phosphate, thiamine hydrochloride, thioctic acid, zinc ascorbate (EMERGEN C), zinc (MANUFACTURER UNKNOWN), all taken from unknown dates for unspecified indications and birth control pills (MANUFACTURER UNKNOWN). The patient previously took pork and its derivatives and bees. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05Apr2021 at 18:15 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Apr2021, within 15 minutes of vaccine, the patient experienced severe neck and shoulder pain on injection side and on the same day, the patient experienced extreme tiredness, extreme body ache, muscle pain and nausea. The clinical outcome of the events severe neck and shoulder pain on injection side, extreme tiredness, extreme body ache, muscle pain and nausea were resolved on an unknown date in Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Heart rate increased, Hyperhidrosis, Lymphadenopathy, Vaccination site erythema
Clinical narrative: Swollen lymph nodes (very painful); Red, swollen, raised rash at injection site; Red, swollen, raised rash at injection site; Red, swollen, raised rash at injection site; Fatigue; Deep sweat; elevated heart rate; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the arm left on 30Apr2021 at 08:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included sambucus nigra (ELDERBERRY), allium sativum, ganoderma lucidum, lentinus edodes, hericium erinaceus, inonotus obliquus (MUSHROOM IMMUNE SUPPORT), benzalkonium chloride, sodium chloride (ALIVE) and multiv; all from unknown date for unspecified indication.  The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the arm left on 10Apr2021 at 08:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation and Penicillin on unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021 at 01:30, the patient experienced swollen lymph nodes (very painful), red, swollen, raised rash at injection site, fatigue, deep sweat and elevated heart rate. The clinical outcome of the events swollen lymph nodes (very painful), red, swollen, raised rash at injection site, fatigue, deep sweat and elevated heart rate was not resolved.  No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site rash, Vaccination site swelling
Clinical narrative: Swollen lymph nodes (very painful); Red, swollen, raised rash at injection site; Red, swollen, raised rash at injection site; Red, swollen, raised rash at injection site; Fatigue; Deep sweat; elevated heart rate; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the arm left on 30Apr2021 at 08:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included sambucus nigra (ELDERBERRY), allium sativum, ganoderma lucidum, lentinus edodes, hericium erinaceus, inonotus obliquus (MUSHROOM IMMUNE SUPPORT), benzalkonium chloride, sodium chloride (ALIVE) and multiv; all from unknown date for unspecified indication.  The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the arm left on 10Apr2021 at 08:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation and Penicillin on unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021 at 01:30, the patient experienced swollen lymph nodes (very painful), red, swollen, raised rash at injection site, fatigue, deep sweat and elevated heart rate. The clinical outcome of the events swollen lymph nodes (very painful), red, swollen, raised rash at injection site, fatigue, deep sweat and elevated heart rate was not resolved.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue
Clinical narrative: Tired; Chills; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 01May2021 at 16:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included exercise induced asthma and foot surgery. Patient did not receive any medication within two weeks of vaccination. Past drug history included penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 02May2021 at 04:00, the patient experienced chills, soreness and tired. The clinical outcome of the event chills, soreness and tired were not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Pain, Peripheral swelling, Skin discolouration
Clinical narrative: Fatigue; Body aches; Diarrhea; Swelling in the arm; Covid toes; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 30Apr2021 at 10:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included the patient had known allergies to penicillin and latex. Concomitant medication was not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the arm left on an 02Apr2021 at 18:00 (at the age of 37-years-old) , as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021 at 09:00, the patient experienced fatigue, body aches, diarrhea, covid toes, swelling in the arm. Therapeutic measures taken were not reported. The clinical outcome of the events fatigue, body aches, diarrhea, covid toes, swelling in the arm was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Headache, Pain, Pain in extremity, Pyrexia
Clinical narrative: This is a spontaneous report from a non-contactable consumer, the patient. A 24-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included cannabidiol (CBD OIL), paracetamol (TYLENOL), multivitamins and ibuprofen (ADVIL), all for unknown indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0171) via an unspecified route of administration on an unknown date in Apr2021 (at the age of 24-years-old), as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date, the patient experienced fever of 38c that lasted all night after second shot, body ache, headache for 2 days and left arm soreness for few days. The clinical outcome of the events fever of 38c that lasted all night after second shot, body ache, headache for 2 days and left arm soreness for few days were recovered on an unknown date.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, SARS-CoV-2 test
Clinical narrative: Rash (dermatitis) break out on chest; This is a spontaneous report from a contactable consumer, the patient. A 34-years-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EW0171) via an unspecified route of administration in the in the right arm on 26Apr2021 (at the age of 34-years-old) as a dose for COVID-19 immunisation. Medical history included shellfish allergy. Concomitant medications included amoxicillin, clavulanic acid (AUGMENTIN) from an unknown date, for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Apr2021 the patient experienced rash (dermatitis) break out on chest. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of adverse event and included treatment with hydroxyzine. On an unknown date, the patient underwent rapid COVID-19 test and the result was negative. The clinical outcome of the event of rash was recovered an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain, Pyrexia
Clinical narrative: Fever; Fatigue; Headache; Body ache; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO179) via an unspecified route of administration in the right arm on 30Apr2021 at 03:15 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included sickle cell trait. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8729), via an unspecified route of administration in the right arm on 09Apr2021 at 13:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 01May2021 at 10:30, the patient experienced fever, fatigue, headache and body ache. The clinical outcome of the events fever, fatigue, headache and body ache were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Fatigue, Pain, Pyrexia
Clinical narrative: Total body soreness and fatigue; Total body soreness and fatigue; 2. Fever like symptoms without fever; Cough sporadically; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170), via an unspecified route of administration in the left arm on 01May2021 at 09:00 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included cetirizine hydrochloride (ZYRTEC) and diphenhydramine hydrochloride (BENADRYL); both started on an unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731), via an unspecified route of administration in the left arm on 10Apr2021 at 15:00 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021 at 19:00, the patient experienced total body soreness and fatigue, fever like symptoms without fever and cough sporadically. The clinical outcome of the events total body soreness and fatigue, fever like symptoms without fever and cough sporadically were recovering at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: headache; tiredness; This is a spontaneous report from a contactable consumer. A male patient of an unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. On an unknown date the patient experienced headache and tiredness. It was reported by the reporter that during chatting with a friend, he said he had headache and tiredness after receiving the 1st dose and he did not experience any side effects. The clinical outcome of the events headache and tiredness were recovered on an unknown date.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Tingling in thumb first finger and middle finger, then entire hand then forearm. Came and went within the first hour.; This is a spontaneous report from a contactable other healthcare professional. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Apr2021 at 14:00 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 13Apr2021 at 14:30, the patient experienced tingling in thumb, first finger and middle finger, then entire hand and then forearm. It came and went within the first hour. The clinical outcome of the event tingling in thumb, first finger and middle finger, then entire hand and then forearm was recovered on an unknown date in 2021.   No follow-up attempts are needed; Information about lot/batch number cannot be obtained.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Malaise, Myalgia
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 74-year-old male patient received the unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: Ew0162) via an unspecified route of administration in the left arm on 27Apr2021 at 15:45 (at the age of 74-years-old) as a single dose for COVID-19 immunization. Medical history included COVID-19. The patient previously received sulfur (MANUFACTURER UNKNOWN) for unknown indication on unknown date and experienced allergy. The concomitant medication was taken by the patient (unspecified) within two weeks prior to COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Apr2021 at 15:45 the patient experienced nausea, tiredness, headache, muscle pain, joint pain, fever and feeling unwell. The clinical outcome of the events nausea, tiredness, headache, muscle pain, joint pain, fever and feeling unwell was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 74-year-old male patient received the unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: Ew0162) via an unspecified route of administration in the left arm on 27Apr2021 at 15:45 (at the age of 74-years-old) as a single dose for COVID-19 immunization. Medical history included COVID-19. The patient previously received sulfur (MANUFACTURER UNKNOWN) for unknown indication on unknown date and experienced allergy. The concomitant medication was taken by the patient (unspecified) within two weeks prior to COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Apr2021 at 15:45 the patient experienced nausea, tiredness, headache, muscle pain, joint pain, fever and feeling unwell. The clinical outcome of the events nausea, tiredness, headache, muscle pain, joint pain, fever and feeling unwell was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort
Clinical narrative: Felt as if my legs were far more heavy when climbing stairs or walking; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6204) via an unspecified route of administration in the left arm on13Mar2021 at 11:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8734) via an unspecified route of administration in the left arm on an unknown date, as a single dose for COVID-19 immunisation. Medical history included cancer in left breast from an unknown date. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in 2021, after the first dose of vaccination, the patient felt as if her legs were far more heavy when climbing stairs or walking and on an unknown date after the second dose of vaccination, the patient's legs felt super heavy so she weighed herself to make sure she had not gained weight. The patient had not gained any weight. Then her right leg felt horrible behind the knee area and on 01May2021 at 21:00, the patient felt her knee area give out and she grabbed the edge of the checkout conveyor belt area. The patient's right leg still felt horrible and she couldn't walk the same as prior to the vaccine. The patient's legs had no problems and she walked fine and her legs did not feel as if steel weights. The clinical outcome of the event felt as if my legs were far more heavy was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: Always been having sinus problem and since got the covid-19 shot it has stop sinus problem since the vaccine had no sinus at all; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 02Apr2021 at 12:15 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included sinus. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 12:00, the patient always been having sinus problem and since he got the COVID-19 shot it has stopped his sinus problem since the vaccine, he had no sinus at all. The clinical outcome of the event always been having sinus problem and since he got the covid-19 shot it has stopped his sinus problem since the vaccine, he had no sinus at all was unknown. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 24Apr2021 at 12:15 (at the age of 46-year-old) as a single dose for COVID-19 immunisation.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Vomiting
Clinical narrative: Severe vomiting; chills; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0171), via an unspecified route of administration in the right arm on 29Apr2021 at 11:45 (at the age of 21-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were reported as none. The patient previously took gluten for celiac disease. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732), via an unspecified route of administration in the left arm on 08Apr2021 at 11:45 (at the age of 21-year-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 03:00, the patient experienced severe vomiting for 4 hours that night and chills. The clinical outcome of the events severe vomiting and chills were resolving.  No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Medial tibial stress syndrome, Pain in extremity
Clinical narrative: Right arm sore; left knee/shin/calf pain; left knee/shin/calf pain; left knee/shin/calf pain; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the arm right on 30Apr2021 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included levothyroxine sodium (LEVOTHYROXIN), rabeprazole (MANUFACTURER UNKNOWN) and losartan (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication. The patient previously took Avelox, penicillin and sulfa on unknown date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021 the patient experienced right arm sore, left knee, shin and calf pain. The patient stated that she had right arm sore but was not bad. However next morning she woke up with left knee/shin/calf pain and she could not put weight on it throughout the day and night. She further stated that her knee and shin got better on second day morning but calf was still stiff and sore. The clinical outcome of the events right arm sore, left knee pain and shin pain and calf pain was unknown.   No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Hypoaesthesia oral, Nasal congestion, Nasopharyngitis, Rhinorrhoea
Clinical narrative: cold-like symptoms; runny nose; stuffy nose; sneezing; congested sinus headache; loss of taste; numbness in mouth; This is a spontaneous report from a contactable pharmacist, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW 0175) via an unspecified route of administration in the left arm on 29Apr2021 at 09:45 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. Medical history included hypothyroidism.  Concomitant medications were not reported. The patient previously took cephalosporin nos (MANUFACTURER UNKNOWN) for unspecified indication from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW 0150) via an unspecified route of administration in the left arm on 08Apr2021 at 09:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021, the patient experienced significant cold-like symptoms - runny nose, stuffy nose, sneezing, congested sinus headache, loss of taste and numbness in mouth. Therapeutic measures were taken as a result of the reported events and included treatment with zyrtec, sudafed, and advil. The clinical outcome of the event cold symptoms, runny nose, nasal congestion, sneezing, sinus headache, loss of taste and numbness mouth were not recovered at the time of report.   No follow-up attempts are possible. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Sinus headache, Sneezing
Clinical narrative: cold-like symptoms; runny nose; stuffy nose; sneezing; congested sinus headache; loss of taste; numbness in mouth; This is a spontaneous report from a contactable pharmacist, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW 0175) via an unspecified route of administration in the left arm on 29Apr2021 at 09:45 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. Medical history included hypothyroidism.  Concomitant medications were not reported. The patient previously took cephalosporin nos (MANUFACTURER UNKNOWN) for unspecified indication from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW 0150) via an unspecified route of administration in the left arm on 08Apr2021 at 09:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02May2021, the patient experienced significant cold-like symptoms - runny nose, stuffy nose, sneezing, congested sinus headache, loss of taste and numbness in mouth. Therapeutic measures were taken as a result of the reported events and included treatment with zyrtec, sudafed, and advil. The clinical outcome of the event cold symptoms, runny nose, nasal congestion, sneezing, sinus headache, loss of taste and numbness mouth were not recovered at the time of report.   No follow-up attempts are possible. No further information is expected.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Left wrist became very sore and painful; This is a spontaneous report from a contactable consumer, the patient. A 84-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 30Apr2021 at 11:30(at the age of 84-year-old) as a single dose for COVID-19 immunisation. The patient no medical history. The patient did not take any concomitant medication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 01May2021 at 11:30 about 24hours after the vaccination, the patient experienced Left wrist became very sore and painful started. Called for assistance and information but only received message that she was 'next party in queue' for over 45 minutes. The clinical outcome of the event Left wrist became very sore and painful was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Fever of 103 degrees Fahrenheit (39.4 degrees Celsius) for 12 hours, 102 degrees Fahrenheit (38.9 degrees Celsius) for 24 hours.; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the right arm on 30Apr2021 at 10:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications included levothyroxine sodium (SYNTHROID) and prenatal vitamins (RITUAL), both for unknown indications from unknown dates. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 09Apr2021 at 14:30 (at the age of 34-years-old), as single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 at 23:00 the patient experienced fever of 103 degrees Fahrenheit (39.4 degrees Celsius) for 12 hours and 102 degrees Fahrenheit (38.9 degrees Celsius) for 24 hours and was unable to reduce the fever with Tylenol. On 30Apr2021 at 23:00, the patient underwent test for body temperature and the result was fever of 103 degrees Fahrenheit (39.4 degrees Celsius) and on 01May2021 at 11:00, the patient's body temperature was 102 degrees Fahrenheit (38.9 degrees Celsius). Therapeutic measures were taken as a result of fever and included treatment with acetaminophen (TYLENOL). The clinical outcome of the event fever was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Headache, Hyperhidrosis, Insomnia, Myalgia
Clinical narrative: Fever that went up to 103.5; Severe headache; Couldn't sleep through the nights.; Tons of sweating.; Muscle pains; Sore throat; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep6955), via an unspecified route of administration in the left arm on an unknown date (at the age of 19-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date, the patient experienced fever that went up to 103.5, severe headaches, couldn't sleep through the nights with tons of sweating, muscle pains and a sore throat. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Medicine was taken as a therapeutic measure for the reported events. On an unknown date, the patient underwent nasal swab and the result was negative. On an unknown date, the patient underwent lab test which included body temperature and the result was 103.5 (units unspecified). The clinical outcome of the events fever that went up to 103.5, severe headaches, couldn't sleep through the nights with tons of sweating, muscle pains and a sore throat were resolving at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pyrexia, SARS-CoV-2 test
Clinical narrative: Fever that went up to 103.5; Severe headache; Couldn't sleep through the nights.; Tons of sweating.; Muscle pains; Sore throat; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep6955), via an unspecified route of administration in the left arm on an unknown date (at the age of 19-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date, the patient experienced fever that went up to 103.5, severe headaches, couldn't sleep through the nights with tons of sweating, muscle pains and a sore throat. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Medicine was taken as a therapeutic measure for the reported events. On an unknown date, the patient underwent nasal swab and the result was negative. On an unknown date, the patient underwent lab test which included body temperature and the result was 103.5 (units unspecified). The clinical outcome of the events fever that went up to 103.5, severe headaches, couldn't sleep through the nights with tons of sweating, muscle pains and a sore throat were resolving at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular
Clinical narrative: menstrual cycle changed; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0151), via an unspecified route of administration in the left arm on 22Apr2021 at 10:00 (at the age of 35-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none.  Concomitant medication was not reported.  The patient did not have any history of past drug therapy. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Apr2021 at 07:00, the patient believed that the vaccine changed menstrual cycle. The patients period began about a week earlier than expected, about 24 days after previous period ended. The patient did not experience any other additional symptoms. The clinical outcome of the event menstrual cycle changed was unknown.   No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Hangover, Pyrexia
Clinical narrative: feeling light headedness; Fever; hangover type feeling in head; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Apr2021 at 10:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history and Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 01Apr2021 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 22Apr2021, right after receiving the vaccine, the patient experienced light headedness, fever and hangover type feeling. After 10 days, fever and light headedness were gone but patient still got hangover type feeling in head and it was mostly in front part of head. The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of events fever and light-headedness were recovered on an unspecified date in 2021. The clinical outcome of event hangover type feeling in head was not recovered at the time of report.  No follow up attempts are needed. Information about lot/batch number cannot be obtained.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Nausea, Pain in extremity
Clinical narrative: sore arm; fever; chills; headache; nausea; every joint in body hurt; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172), via an unspecified route of administration in the right arm on 28Apr2021 at 11:30 (at the age of 64-year-old), as a single dose for COVID-19 immunisation. Medical history included COPD (Chronic obstructive pulmonary disease). Concomitant medications included metoprolol succinate (TOPROL XL 25 milligrams). The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150), via an unspecified route of administration in the right arm on 30Mar2021 at 11:30 (at the age of 64-year-old), as a single dose for COVID-19 immunisation and experienced sore arm on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, on the second dose the patient experienced sore arm again but also had a fever, chills, headache, nausea and every joint in the body hurt. The clinical outcome of the events sore arm, fever, chills, headache, nausea and every joint in the body hurt was resolved on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: sore arm; fever; chills; headache; nausea; every joint in body hurt; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172), via an unspecified route of administration in the right arm on 28Apr2021 at 11:30 (at the age of 64-year-old), as a single dose for COVID-19 immunisation. Medical history included COPD (Chronic obstructive pulmonary disease). Concomitant medications included metoprolol succinate (TOPROL XL 25 milligrams). The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150), via an unspecified route of administration in the right arm on 30Mar2021 at 11:30 (at the age of 64-year-old), as a single dose for COVID-19 immunisation and experienced sore arm on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, on the second dose the patient experienced sore arm again but also had a fever, chills, headache, nausea and every joint in the body hurt. The clinical outcome of the events sore arm, fever, chills, headache, nausea and every joint in the body hurt was resolved on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.